Steve Offord

883 total citations
19 papers, 662 citations indexed

About

Steve Offord is a scholar working on Psychiatry and Mental health, Social Psychology and Philosophy. According to data from OpenAlex, Steve Offord has authored 19 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 5 papers in Social Psychology and 5 papers in Philosophy. Recurrent topics in Steve Offord's work include Schizophrenia research and treatment (14 papers), Mental Health Treatment and Access (5 papers) and Mental Health and Psychiatry (5 papers). Steve Offord is often cited by papers focused on Schizophrenia research and treatment (14 papers), Mental Health Treatment and Access (5 papers) and Mental Health and Psychiatry (5 papers). Steve Offord collaborates with scholars based in United States, Spain and Sweden. Steve Offord's co-authors include Bruce Wong, Jay Lin, Anna Eramo, Dario Mirski, Ruth A. Duffy, Vladimir Maletic, Craig N. Karson, Ross A. Baker, Peter J. Weiden and Noam Y. Kirson and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Steve Offord

19 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Offord United States 14 459 155 136 76 72 19 662
Jessica L. Gören United States 14 484 1.1× 119 0.8× 95 0.7× 64 0.8× 112 1.6× 28 719
Hung‐Yu Chan Taiwan 17 443 1.0× 168 1.1× 61 0.4× 85 1.1× 94 1.3× 57 789
Ján Pečeňák Slovakia 15 454 1.0× 207 1.3× 84 0.6× 91 1.2× 49 0.7× 47 683
André Tapp United States 13 532 1.2× 153 1.0× 106 0.8× 55 0.7× 134 1.9× 29 887
Monika Edlinger Austria 14 710 1.5× 217 1.4× 217 1.6× 131 1.7× 76 1.1× 33 875
Seema Quraishi United Kingdom 14 1.0k 2.2× 239 1.5× 177 1.3× 47 0.6× 98 1.4× 20 1.2k
Pamela Perry United States 15 655 1.4× 133 0.9× 127 0.9× 34 0.4× 154 2.1× 34 852
Gabi Pitschel‐Walz Germany 8 426 0.9× 192 1.2× 128 0.9× 64 0.8× 67 0.9× 13 564
Cedric O’Gorman United States 13 450 1.0× 107 0.7× 78 0.6× 45 0.6× 82 1.1× 31 609
Herbert Pfeiffer Germany 20 659 1.4× 245 1.6× 209 1.5× 123 1.6× 128 1.8× 33 969

Countries citing papers authored by Steve Offord

Since Specialization
Citations

This map shows the geographic impact of Steve Offord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Offord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Offord more than expected).

Fields of papers citing papers by Steve Offord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Offord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Offord. The network helps show where Steve Offord may publish in the future.

Co-authorship network of co-authors of Steve Offord

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Offord. A scholar is included among the top collaborators of Steve Offord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Offord. Steve Offord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Wilson, Michele, Steve Offord, Christopher Blanchette, et al.. (2016). Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia. Drugs in Context. 5. 1–10. 4 indexed citations
3.
Karson, Craig N., Ruth A. Duffy, Anna Eramo, Anna‐Greta Nylander, & Steve Offord. (2016). Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review. Neuropsychiatric Disease and Treatment. 12. 57–57. 63 indexed citations
4.
5.
Citrome, Leslie, Anna Eramo, C. François, et al.. (2015). Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment. 11. 3095–3095. 16 indexed citations
6.
Lawson, William, Craig N. Karson, Steve Offord, et al.. (2015). Racial Differences in Antipsychotic Use: Claims Database Analysis of Medicaid-Insured Patients with Schizophrenia. Annals of Clinical Psychiatry. 27(4). 242–252. 19 indexed citations
8.
Kirson, Noam Y., Peter J. Weiden, Thomas W. Samuelson, et al.. (2013). Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia. The Journal of Clinical Psychiatry. 74(6). 568–575. 143 indexed citations
9.
Offord, Steve, Jay Lin, Dario Mirski, & Bruce Wong. (2013). Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia. Advances in Therapy. 30(3). 286–297. 59 indexed citations
11.
Offord, Steve, Jay Lin, Bruce Wong, Dario Mirski, & Ross A. Baker. (2013). Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage. Community Mental Health Journal. 49(6). 625–629. 21 indexed citations
12.
Lin, Jay, Bruce Wong, Steve Offord, & Dario Mirski. (2013). Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia. The Journal of Behavioral Health Services & Research. 40(3). 355–366. 42 indexed citations
13.
Offord, Steve, Bruce Wong, Dario Mirski, Ross A. Baker, & Jay Lin. (2012). Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral. Journal of Medical Economics. 16(2). 231–239. 56 indexed citations
14.
Offord, Steve, Dean F. Wong, & Svante Nyberg. (1999). The Role of Positron Emission Tomography in the Drug Development of M100907, a Putative Antipsychotic with a Novel Mechanism of Action. The Journal of Clinical Pharmacology. 39(S1). 17S–24S. 22 indexed citations
15.
Seibyl, John, Yolanda Zea‐Ponce, Ronald M. Baldwin, et al.. (1996). Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.. PubMed. 37(1). 11–5. 18 indexed citations
16.
Offord, Steve, et al.. (1995). The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain. Brain Research. 677(2). 250–256. 8 indexed citations
17.
Sanfilippo, Pauline J., et al.. (1995). Novel Thiazole-Based Heterocycles as Selective Inhibitors of Fibrinogen-Mediated Platelet Aggregation. Journal of Medicinal Chemistry. 38(1). 34–41. 20 indexed citations
18.
Offord, Steve, et al.. (1987). Differential effects of nialamide and clomipramine on serotonin efflux and autoreceptors. Pharmacology Biochemistry and Behavior. 26(3). 593–600. 3 indexed citations
19.
Offord, Steve, et al.. (1984). Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus. European Journal of Pharmacology. 104(3-4). 379–382. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026